Drugs, Devices, Software, Diagnostics for the Brain and Nervous System

Where : Hotel Kempinski, Geneva
When : September 9-10

This is the 3rd biannual European Neurotech Investing and Partnering Conference and the first held in Geneva, Switzerland.  It is the premier partnering and investing conference for the neurotechnology industry including pharmaceuticals, medical devices, software and diagnostics for the brain and nervous system.

Organized by the Neurotechnology Industry Organization and our partner NeuroInsights, the 3rd bi-annual conference will be held on Tuesday and Wednesday, September 9-10, 2015 at the Grand Hotel Kempinski in Geneva, Switzerland.

The European Neurotech Investing and Partnering Conference is a global forum where investors, executives, entrepreneurs, scientists and others involved in the development of new treatments and diagnostics for the brain and nervous system come together to shape the future of their organization and the industry.

This market defining conference features keynotes on the state of the neurotech industry in Europe and the world, cutting edge company presentations, leading translational research projects and panel discussions on a comprehensive selection of neurotech topics.

Hear about next generation treatments for Alzheimer's, addiction, anxiety, autism, depression, pain, sensory disorders, obesity, stroke, schizophrenia, sleep disorders, epilepsy, multiple sclerosis, traumatic brain injury, spinal cord injury, Parkinson's and more.

You'll get a first-hand glimpse of What's in the Pipeline

  • Find out about new product licensing and partnering opportunities
  • Learn what venture and strategic investors are looking for
  • Discover emerging technologies and companies
  • Learn about cutting edge translational research and funding opportunities
  • Plan networking and schedule meetings ahead of time with other attendees


Advisory Board

  • Zack Lynch, Founder and CEO, Neurotechnology Industry Organization
  • Henry Markram, Founder, Human Brain Project, Prof. EPFL
  • John Donoghue, Director, Wyss Center for Bio and Neuroengineering
  • Don deBethizy, President, Innovent
  • Manuel Lopez-Figueroa, Vice President, Bay City Capital
  • Peter Moldt, Partner, Novo Ventures
  • Roger Quy, General Partner, Technology Partners
  • David Lowe, CEO, NeuroAssets
  • Antoine Papiernik, Managing Partner, Sofinnova Ventures & MD Start
  • Killu Sanborn, Director of Business Development, Oxford Finance


Media

We welcome the official press. Must be verified media. To request a press pass please send relevant information with copies of articles to (limited passes available).


Cancellation Policy


After August 1st, due to commitments to vendors, no refunds are available for cancellations or no-shows. Prior to August 1, cancellations will be charged a 0 processing fee.

 

MORE INFO AND REGISTRATION

Find an actor

Medtech Innovation Event - Sept 4 - Swiss Innovation Park Biel/Bienne04.09.2017

Swiss Medtech, be-advanced and Switzerland Innovation Park Biel/Bienne organise the 3rd matchmaking event solely for...

Welcome To Health Valley

Building on skills honed over the centuries, western Switzerland has become a world leader in biotech.
Print this page Download this page (PDF) Recommend this page to a friend

Contact us

BioAlps Association
Ch. du Pré-Fleuri 3
CH - 1228 Plan-les Ouates
+41 22 304 40 40
+41 22 304 40 70

Subscribe to our newsletter

Find us on LinkedIn